We are live on ! Find out more
FMED icon

Fidelity Disruptive Medicine ETF
FMED

8 hedge funds and large institutions have $34.6M invested in Fidelity Disruptive Medicine ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

277% more capital inflows, than outflows

Capital inflows: $4.02M | Capital outflows: $1.07M

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

14% more funds holding

Funds holding: 7 → 8 (+1)

3.5% more ownership

Funds ownership: 62.15% → 65.64% (+3.5%)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.22M
2
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services
Minnesota
+$1.79M
3
UBS Group
UBS Group
Switzerland
+$13.6K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$1.07M

FMED Hedge Fund Activity: Q2 2025 in Review

8 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q2 2025, worth a combined $34.6M — up 11% from $31.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new FMED positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $2.22M. The largest seller was Jane Street, cutting an estimated $1.07M.

  • 8 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q2 2025, up from 7 in Q1 2025.
  • Funds reported $34.6M of Fidelity Disruptive Medicine ETF stock for Q2 2025, up 11% quarter-over-quarter.
  • 1 fund opened new Fidelity Disruptive Medicine ETF positions in Q2 2025 and 0 closed out, a net change of +1 holder.
  • The largest Fidelity Disruptive Medicine ETF buyer in Q2 2025 was Fidelity Investments, an estimated $2.22M added.
  • The largest Fidelity Disruptive Medicine ETF seller in Q2 2025 was Jane Street, an estimated $1.07M sold.

Based on aggregated 13F filings for Q2 2025.